{"id":378661,"date":"2026-05-12T13:37:11","date_gmt":"2026-05-12T13:37:11","guid":{"rendered":"https:\/\/www.europesays.com\/pt\/378661\/"},"modified":"2026-05-12T13:37:11","modified_gmt":"2026-05-12T13:37:11","slug":"doenca-de-parkinson-e-melanoma-evidencia-clinica-de-interacao-neuro-oncologica-um-estudo-de-caso","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/pt\/378661\/","title":{"rendered":"Doen\u00e7a de Parkinson e melanoma: evid\u00eancia cl\u00ednica de intera\u00e7\u00e3o neuro-oncol\u00f3gica, um estudo de caso"},"content":{"rendered":"<p>\n<strong>Doen\u00e7a de Parkinson e melanoma: evid\u00eancia cl\u00ednica de intera\u00e7\u00e3o neuro-oncol\u00f3gica, um estudo de caso<\/strong><\/p>\n<p class=\"western\">    <b>Ana L\u00facia Tabaka<\/b>          <b\/>          <b>; Rafael Fiamoncini Ferreira<\/b>          <b\/>     <\/p>\n<p>.<\/p>\n<p class=\"western\" align=\"left\">    <b>Como Citar:<\/b>     <br \/>     TABAKA, Ana L\u00facia; FERREIRA, Rafael Fiamoncini. Doen\u00e7a de Parkinson e melanoma: evid\u00eancia cl\u00ednica de intera\u00e7\u00e3o neuro-oncol\u00f3gica, um estudo de caso.\u00a0Revista Sociedade Cient\u00edfica, vol. 9, n. 1, p. 1171-1187, 2026.     <br \/>  <a href=\"https:\/\/doi.org\/10.61411\/rsc2026130819\" rel=\"nofollow noopener\" target=\"_blank\">   https:\/\/doi.org\/10.61411\/rsc2026130819   <\/a>  <br \/>    <b>DOI:<\/b>   <a href=\"https:\/\/doi.org\/10.61411\/rsc2026130819\" rel=\"nofollow noopener\" target=\"_blank\">   10.61411\/rsc2026130819   <\/a>  <br \/>    <b>\u00c1rea do conhecimento:<\/b>     Ci\u00eancias da Sa\u00fade    <br \/>    <b>Sub-\u00e1rea:<\/b>     Medicina; Neurologia    <br \/>     <b>Palavras-chave:<\/b>       Doen\u00e7a de Parkinson; Melanoma; Neuro-oncologia.     <br \/>     <b>Publicado:<\/b>       7 de maio de 2026.    <\/p>\n<p>.<br \/>\n <b>Resumo<\/b> <\/p>\n<p class=\"western\" style=\"text-align: justify;\">A Doen\u00e7a de Parkinson (DP) \u00e9 uma doen\u00e7a neurodegenerativa, caracterizada pela morte de neur\u00f4nios dopamin\u00e9rgicos, resultando na perda da neurotransmiss\u00e3o de dopamina. Em contrapartida, o c\u00e2ncer \u00e9 caracterizado pelo crescimento desordenado e descontrolado de c\u00e9lulas, no caso do melanoma, ocorre com os melan\u00f3citos. Nas \u00faltimas d\u00e9cadas, estudos t\u00eam sugerido uma poss\u00edvel correla\u00e7\u00e3o entre essas duas patologias. Os achados indicam que essa associa\u00e7\u00e3o pode estar relacionada com medicamentos utilizados para o tratamento da DP, por fatores gen\u00e9ticos e\/ou ambientais. Dessa forma, o presente estudo tem como objetivo verificar a exist\u00eancia de poss\u00edvel correla\u00e7\u00e3o entre a Doen\u00e7a de Parkinson e o c\u00e2ncer de pele melanoma. A metodologia adotada consistiu em uma revis\u00e3o integrativa da literatura, aliada a um estudo de caso, visando compreender de forma mais aprofundada essa poss\u00edvel associa\u00e7\u00e3o. Os resultados obtidos sugerem uma correla\u00e7\u00e3o significativa entre a DP e o melanoma, possivelmente explicada por mecanismos gen\u00e9ticos, pelo tratamento e associa\u00e7\u00f5es bioqu\u00edmicas, ressaltando a import\u00e2ncia de um acompanhamento cl\u00ednico integrado e preventivo em pacientes acometidos por essas patologias.<\/p>\n<p><a class=\"maxbutton-1 maxbutton maxbutton-rede-social-cientifica\" target=\"_blank\" title=\"Acesso\" rel=\"noopener nofollow\" href=\"https:\/\/show.scientificsociety.net\/2026\/05\/doenca-de-parkinson-e-melanoma-evidencia-clinica-de-interacao-neuro-oncologica-um-estudo-de-caso\/\">Artigo<\/a><br \/>\n.<br \/>\n<a class=\"maxbutton-1 maxbutton maxbutton-rede-social-cientifica\" target=\"_blank\" title=\"Acesso\" rel=\"noopener nofollow\" href=\"https:\/\/journal.scientificsociety.net\/index.php\/sobre\/issue\/view\/31\">Sum\u00e1rio<\/a><br \/>\n.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-1135 aligncenter\" src=\"https:\/\/www.europesays.com\/pt\/wp-content\/uploads\/2025\/08\/Qualis-B2-243x300.jpg\" alt=\"\" width=\"243\" height=\"300\"  \/><\/p>\n<p>.<\/p>\n<p>                    <\/p>\n","protected":false},"excerpt":{"rendered":"Doen\u00e7a de Parkinson e melanoma: evid\u00eancia cl\u00ednica de intera\u00e7\u00e3o neuro-oncol\u00f3gica, um estudo de caso Ana L\u00facia Tabaka ;&hellip;\n","protected":false},"author":2,"featured_media":378662,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[63533,63534,29610,29611,29612,5080,5081,29615,29616,29617,3888,63535,29618,29619,63536,48331,48332,6374,63537,63538,63539,63540,63541,63542,4805,5492,6447,4662,7362,63543,63544,63545,63546,63547,63548,63549,5112,50720,63550,63551,63552,116,48357,29662,29663,29665,5130,63553,48363,63554,63555,29666,29668,57346,5143,63556,63557,63558,5502,63559,5147,5148,61324,11604,63560,63561,29676,63562,63563,63564,43583,63565,63566,63567,7654,7370,63568,63504,63569,63570,63571,7225,63572,31274,29677,29678,63573,63574,5152,5153,5154,32,1461,60816,7499,33,5158,5160,5161,5162,5163,5164,5165,5166,5167,29686,29687,29688,29689,29690,29691,29692,29693,29694,5168,5169,29695,5170,48385,63575,5175,5176,5177,5178,5179,5180,5181,63576,63577,117,5183,29704,29705,29706,63578,4205,5193,5194,5195,29710,63579,61354,63580,63581,63582],"class_list":{"0":"post-378661","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-saude","8":"tag-acompanhamento-clinico-integrado","9":"tag-antiparkinsonian-drugs","10":"tag-article-submission","11":"tag-article-submissions","12":"tag-article-template","13":"tag-artigo-cientifico","14":"tag-artigo-online","15":"tag-brazilian-journal","16":"tag-brazilian-journals","17":"tag-brazilian-scientific-journal","18":"tag-cancer-de-pele","19":"tag-cancer-de-piel","20":"tag-capes-journal","21":"tag-capes-qualis","22":"tag-case-study","23":"tag-ciencias-da-saude","24":"tag-ciencias-de-la-salud","25":"tag-comorbidade","26":"tag-comorbidity","27":"tag-comorbilidad","28":"tag-correlacao-parkinson-melanoma","29":"tag-correlacion-parkinson-melanoma","30":"tag-crecimiento-celular-desordenado","31":"tag-crescimento-celular-desordenado","32":"tag-dermatologia","33":"tag-dermatology","34":"tag-doenca-de-parkinson","35":"tag-dopamina","36":"tag-dopamine","37":"tag-dopaminergic-neurons","38":"tag-enfermedad-de-parkinson","39":"tag-environmental-factors","40":"tag-estudio-de-caso","41":"tag-estudo-de-caso","42":"tag-factores-ambientales","43":"tag-factores-geneticos","44":"tag-fator-de-imapacto","45":"tag-fatores-ambientais","46":"tag-fatores-geneticos","47":"tag-genetic-factors","48":"tag-genetic-mutation","49":"tag-health","50":"tag-health-sciences","51":"tag-high-impact-journal","52":"tag-high-impact-journals","53":"tag-impact-factor","54":"tag-impacto-factor","55":"tag-integrated-clinical-follow-up","56":"tag-integrative-review","57":"tag-interacao-neuro-oncologica","58":"tag-interaccion-neuro-oncologica","59":"tag-international-journal","60":"tag-journal","61":"tag-levodopa","62":"tag-livro-cientifico","63":"tag-medicamentos-antiparkinsonianos","64":"tag-melanocitos","65":"tag-melanocytes","66":"tag-melanoma","67":"tag-melanoma-risk","68":"tag-modelo-de-artigo","69":"tag-modelo-de-artigo-cientifico","70":"tag-movement-disorder","71":"tag-movimento","72":"tag-mutacao-genetica","73":"tag-mutacion-genetica","74":"tag-national-journal","75":"tag-neuro-oncologia","76":"tag-neuro-oncological-interaction","77":"tag-neuro-oncology","78":"tag-neurodegeneracao","79":"tag-neurodegeneracion","80":"tag-neurodegeneration","81":"tag-neurodegenerative-disorder","82":"tag-neurologia","83":"tag-neurology","84":"tag-neuronas-dopaminergicas","85":"tag-neuronios-dopaminergicos","86":"tag-neuroprotecao","87":"tag-neuroproteccion","88":"tag-neuroprotection","89":"tag-oncologia","90":"tag-oncological-surveillance","91":"tag-oncology","92":"tag-online-article","93":"tag-online-journal","94":"tag-parkinson-melanoma-correlation","95":"tag-parkinsons-disease","96":"tag-periodico","97":"tag-periodico-da-capes","98":"tag-periodico-nacional","99":"tag-portugal","100":"tag-prevencao","101":"tag-prevencion","102":"tag-prevention","103":"tag-pt","104":"tag-publciar-resumo","105":"tag-publicar-artigo","106":"tag-publicar-artigo-cientifico","107":"tag-publicar-capitulo-de-livro","108":"tag-publicar-dissertacao","109":"tag-publicar-monografia","110":"tag-publicar-resumo-cientifico","111":"tag-publicar-tcc","112":"tag-publicar-tese","113":"tag-publish-abstract","114":"tag-publish-article","115":"tag-publish-book-chapter","116":"tag-publish-dissertation","117":"tag-publish-monograph","118":"tag-publish-scientific-abstract","119":"tag-publish-scientific-article","120":"tag-publish-thesis","121":"tag-publish-undergraduate-thesis","122":"tag-qualis","123":"tag-qualis-capes","124":"tag-qualis-reference","125":"tag-qualis-referencia","126":"tag-revisao-integrativa","127":"tag-revision-integrativa","128":"tag-revista-brasileira","129":"tag-revista-cientifica-brasileira","130":"tag-revista-de-impacto","131":"tag-revista-internacional","132":"tag-revista-online","133":"tag-revistas-brasilieras","134":"tag-revistas-de-impacto","135":"tag-riesgo-de-melanoma","136":"tag-risco-de-melanoma","137":"tag-saude","138":"tag-scielo","139":"tag-scientific-article","140":"tag-scientific-article-template","141":"tag-scientific-book","142":"tag-seguimiento-clinico-integrado","143":"tag-skin-cancer","144":"tag-submeter-artigo","145":"tag-submissao-de-artigo","146":"tag-submissao-de-artigos","147":"tag-submit-article","148":"tag-transtorno-neurodegenerativo","149":"tag-trastorno-del-movimiento","150":"tag-trastorno-neurodegenerativo","151":"tag-uncontrolled-cell-growth","152":"tag-vigilancia-oncologica"},"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/posts\/378661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/comments?post=378661"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/posts\/378661\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/media\/378662"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/media?parent=378661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/categories?post=378661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/tags?post=378661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}